Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details 5)

v3.20.1
Stockholders' Equity (Details 5)
9 Months Ended
Mar. 31, 2020
$ / shares
shares
Number of stock options outstanding  
Beginning balance | shares 84,990
Granted | shares 491,817
Vested | shares (329,202)
Ending balance | shares 247,605
Weighted average exercise price  
Beginning balance $ 11.35
Granted 0.61
Vested 2.15
Ending balance 2.25
Weighted Average Grant Date Fair Value  
Weighted average grant date fair value, Beginning balance 5.82
Weighted average grant date fair value, Granted 0.40
Weighted average grant date fair value, Vested 1.18
Weighted average grant date fair value, Ending balance $ 1.23